Psychedelic Drugs Going Mainstream
Drug maker Eli Lilly recently purchased psychedelic drug manufacturer, AtaiBeckley, signaling a new interest in psychedelic drugs.
NIDA Investigates Use of Psychedelic Drugs to Treat Substance Use Disorders
The director of the National Institute on Drug Abuse encourages research into psychedelic drugs for the treatment of substance use disorders.
“Magic Mushroom” Study Will Look at Treating Addiction, Trauma
A University of Washington School of Medicine study will look into the therapeutic potential of psychedelic mushrooms in treating addiction and trauma.